Internal Medicine, Endocrinology, Diabetes, & Metabolism · Cherry Hill, NJ
NPI
1336552397
Since 2014
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1210 Brace Rd Ste 107
Cherry Hill, NJ, 08034
Phone (856) 795-3597
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
765 services
Medicare patients, 2024
395
Average age 70
Drug cost, 2024
$1.7M
4,488 prescriptions
Company payments, 2025
$35.14
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott J Steven was code 99214 (office e&m - established), 447 times for 272 patients. In total Scott J Steven billed 765 services in 12 codes, and Medicare paid $66K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 447 | 272 | $96.06 | $43K |
| 95251 Test - Miscellaneous | Office | 102 | 63 | $27.33 | $2,788 |
| 99204 Office E&M - New | Office | 52 | 52 | $124.22 | $6,459 |
| 99215 Office E&M - Established | Office | 47 | 37 | $124.61 | $5,857 |
| 99232 Hospital E&M - Subsequent | Facility | 43 | 24 | $65.07 | $2,798 |
| 99213 Office E&M - Established | Office | 38 | 31 | $65.94 | $2,506 |
| 99222 Hospital E&M - Initial | Facility | 18 | 18 | $102.04 | $1,837 |
By year: 2022 $72K for 816 services; 2023 $74K for 802 services; 2024 $66K for 765 services.
Medicare prescription drug claims, 2024
In 2024, the drug Scott J Steven prescribed most often to Medicare patients was Levothyroxine Sodium, with 510 prescriptions and refills. In total Scott J Steven wrote 4,488 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 510 | 1,285 | 134 | $6,081 |
| Metformin Hcl Generic | 461 | 1,272 | 148 | $4,900 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 356 | 960 | 125 | $57K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 212 | 565 | 83 | $29K |
| Ozempic Semaglutide | 196 | 403 | 52 | $368K |
| Metformin Hcl Er Metformin Hcl | 136 | 365 | 44 | $1,331 |
| Januvia Sitagliptin Phosphate | 133 | 270 | 34 | $142K |
| Glipizide Generic | 130 | 331 | 38 | $2,102 |
| Jardiance Empagliflozin | 129 | 280 | 38 | $154K |
| Humalog Kwikpen U-100 Insulin Lispro | 104 | 278 | 44 | $40K |
| Novolog Flexpen Insulin Aspart | 104 | 270 | 35 | $38K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 103 | 297 | 37 | $53K |
| Atorvastatin Calcium Generic | 99 | 227 | 26 | $1,021 |
| Trulicity Dulaglutide | 95 | 177 | 27 | $171K |
| Methimazole Generic | 90 | 257 | 28 | $862 |
Brand drugs: 2,147 claims; generic drugs: 1,885 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott J Steven $35.14 ($35.14 in general payments such as food, travel and fees) from 2 companies. The largest payer was Ionis Pharmaceuticals, Inc. with $19.05.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.